Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33848462/

1 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: [email protected]. 2 Centro de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil. 3 Ankara University School of Medicine, Ankara, Turkey. 4 Fudan University Shanghai Cancer Center, Shanghai, China. 5 The First Hospital of Jilin University, Changchun, China.